Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration
David Ricks, chief executive officer of Eli Lilly & Co., speaks during the China Development Forum in Beijing in March this year. Photographer: Qilai Shen/Bloomberg © 2026 Bloomberg Finance LP In the latest China pharmaceutical industry…
Washington and Pharma Are Helping China Win | Opinion
I don't often agree with Health and Human Services Secretary Robert F. Kennedy Jr., but he was right when he told Congress that China is 'eating our lunch' when it comes to developing new treatments and cures. The question facing the United States…
/afaqs/media/media_files/2026/06/24/honasa_fluence-2026-06-24-15-45-54.jpg)
Honasa Consumer enters nutraceuticals with majority stake in Fluence Pharma
Honasa Consumer, the parent company of brands such as Mamaearth, has entered the nutraceuticals category with the acquisition of a 58% stake in Fluence Pharma, a science-led supplements company known for its patented Cyclical Nutrition Therapy…
India pharma sector shifts focus to biosimilars, biologics and high-value growth
The pharmaceutical sector is undergoing a strategic shift from volume-driven expansion to high-value global competitiveness, with increasing emphasis on quality, innovation and trust. Backed by $30 billion in annual exports and the highest number…
ARS Pharmaceuticals (SPRY) Stock Sinks After-Hours After Commercial Update On Neffy Coverage - ARS Pharma
ARS Pharmaceuticals, Inc. (NASDAQ:) shares fell in after-hours trading on Wednesday after the company provided commercial and financial updates, including no new formulary additions for Neffy in the July 2026 coverage cycle. SPRY closed Wednesday's…
With Weight Loss Drugs, There's Evidently No Frontier
Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight loss medicines, Ozempic, Victoza and Wegovy. Its a prescription medicine used with a reduced calorie diet and physical activity. (Photo by: Michael…
Stock Market Today: Why sensex, nifty opened higher as crude slipped near $70 | Dynamite News
Post Published By: Donika Singh Updated: 25 June 2026, 9:46 AM IST New Delhi: Indian stock markets opened higher on Thursday as crude oil prices eased towards the $70-per-barrel mark, with tankers resuming their exit from the Strait of Hormuz…
US decries the 'free ride' countries with public health systems are getting by negotiating deals for prescription drugs
The Trump administration has launched an investigation into Germany's pharmaceutical pricing, claiming that “persistent underpayment” for drugs is forcing Americans to subsidize research and development (R & D) globally. And it's…
Johnson & Johnson: Not Every Dollar Needs To Chase The AI Boom (Upgrade) (NYSE:JNJ)
Johnson & Johnson (JNJ) is upgraded from Hold to Buy, driven by consistent performance, stable revenue growth, and defensive characteristics. JNJ trades at a 20x forward P/E, a justified 12% premium to peers, supported by above-industry margins and…
SETL Expands Into AI Datacenter Engineering With Strategic GScale Energy Acquisition
Hyderabad-based SETL has strategically acquired a majority stake in GScale Energy, committing Rs 500 crore to expand its precision engineering expertise into the burgeoning AI Datacenter infrastructure market, powering India's digital future. SETL…
China detains two Japanese nationals suspected of smuggling banned goods
China has detained two Japanese nationals suspected of smuggling banned goods, Tokyo said on Wednesday after media reported that an employee of a major Japanese electronics firm was among those arrested in a case involving rare earth-related…
Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside
Galectin Therapeutics remains a buy as recent FDA alignment de-risks belapectin's Phase 3 path and clarifies regulatory endpoints. The FDA's endorsement of a single, well-controlled Phase 3 trial with a composite clinical outcome endpoint reduces…
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
Danaher (DHR +5.01%) focuses on life sciences, diagnostics, and industrial solutions for healthcare and sells specialized equipment, software, consumables, and reagents used by pharmaceutical companies, scientific research labs, and hospitals. The…
Indian investors may move to safer bets amid structural challenges: Experts
It may be a safe decision to invest in FMCG, Pharma, IT and Telecom stocks given their historical performance at a time when India is set to face structural challenges to its growth story, said experts at Ambit Institutional Equities. Further…
South San Francisco Biotech Snags Monster $1.9 Billion Cancer Drug Pact With Novartis
Source: Google Street View Antares Therapeutics, a Scorpion spinout with labs in South San Francisco and Boston, has inked a collaboration with Swiss pharma heavyweight Novartis that could be worth about $1.9 billion. The deal folds in an upfront…
Receive a Daily briefing on Pharma Industry News
Get Started